These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9669518

  • 21. Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: role of somatostatin and CRH-binding protein.
    Riedel W, Schlapp U, Leck S, Netter P, Neeck G.
    Ann N Y Acad Sci; 2002 Jun; 966():483-90. PubMed ID: 12114308
    [Abstract] [Full Text] [Related]

  • 22. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 23. A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects.
    Scott LV, Svec F, Dinan T.
    Psychiatry Res; 2000 Dec 04; 97(1):21-8. PubMed ID: 11104854
    [Abstract] [Full Text] [Related]

  • 24. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    J Clin Endocrinol Metab; 1994 Jul 04; 79(1):140-4. PubMed ID: 8027217
    [Abstract] [Full Text] [Related]

  • 25. alpha2-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity.
    Pasquali R, Vicennati V, Calzoni F, Gnudi U, Gambineri A, Ceroni L, Cortelli P, Menozzi R, Sinisi R, Rio GD.
    Clin Endocrinol (Oxf); 2000 Apr 04; 52(4):413-21. PubMed ID: 10762283
    [Abstract] [Full Text] [Related]

  • 26. Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorder.
    Hikichi T, Akiyoshi J, Ichioka S, Tanaka Y, Tsuru J, Goto S, Matsushita H, Hanada H, Isogawa K, Nagayama H.
    Neuropsychobiology; 2007 Apr 04; 55(1):21-7. PubMed ID: 17556849
    [Abstract] [Full Text] [Related]

  • 27. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
    Cleare AJ, O'Keane V, Miell JP.
    Psychoneuroendocrinology; 2004 Jul 04; 29(6):724-32. PubMed ID: 15110921
    [Abstract] [Full Text] [Related]

  • 28. Hypothalamic-Pituitary-Adrenal Axis Responses in Women with Endometriosis-Related Chronic Pelvic Pain.
    Ortiz R, Gemmill JAL, Sinaii N, Stegmann B, Khachikyan I, Chrousos G, Segars J, Stratton P.
    Reprod Sci; 2020 Oct 04; 27(10):1839-1847. PubMed ID: 32572832
    [Abstract] [Full Text] [Related]

  • 29. Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome.
    Lanzone A, Fulghesu AM, Guido M, Cucinelli F, Caruso A, Mancuso S.
    Fertil Steril; 1997 Jan 04; 67(1):34-9. PubMed ID: 8986680
    [Abstract] [Full Text] [Related]

  • 30. Hypothalamic amenorrhea with normal body weight: ACTH, allopregnanolone and cortisol responses to corticotropin-releasing hormone test.
    Meczekalski B, Tonetti A, Monteleone P, Bernardi F, Luisi S, Stomati M, Luisi M, Petraglia F, Genazzani AR.
    Eur J Endocrinol; 2000 Mar 04; 142(3):280-5. PubMed ID: 10700723
    [Abstract] [Full Text] [Related]

  • 31. [Influence of interleukin-1 and interleukin-6 on modulation of hypothalamo-pituitary-adrenal axis in pregnancy at term and in spontaneous and oxytocin-induced delivery].
    Ochedalski T, Lachowicz A.
    Ginekol Pol; 2003 Oct 04; 74(10):1228-35. PubMed ID: 14669422
    [Abstract] [Full Text] [Related]

  • 32. Identification of stimulatory and inhibitory inputs to the hypothalamic-pituitary-adrenal axis during hypoglycaemia or transport in ewes.
    Smith RF, French NP, Saphier PW, Lowry PJ, Veldhuis JD, Dobson H.
    J Neuroendocrinol; 2003 Jun 04; 15(6):572-85. PubMed ID: 12716408
    [Abstract] [Full Text] [Related]

  • 33. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ, Faria M, Newell-Price J, Browne P, Kopelman P, Coy DH, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 1995 Feb 04; 80(2):412-7. PubMed ID: 7852498
    [Abstract] [Full Text] [Related]

  • 34. Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers.
    Amsterdam JD, Maislin G, Winokur A, Kling M, Gold P.
    Arch Gen Psychiatry; 1987 Sep 04; 44(9):775-81. PubMed ID: 2820340
    [Abstract] [Full Text] [Related]

  • 35. Abnormalities in response to vasopressin infusion in chronic fatigue syndrome.
    Altemus M, Dale JK, Michelson D, Demitrack MA, Gold PW, Straus SE.
    Psychoneuroendocrinology; 2001 Feb 04; 26(2):175-88. PubMed ID: 11087963
    [Abstract] [Full Text] [Related]

  • 36. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E, Maccagno B, Ramunni J, Di Vito L, Broglio F, Deghenghi R, Camanni F, Ghigo E.
    Neuroendocrinology; 1997 Dec 04; 66(6):432-8. PubMed ID: 9430449
    [Abstract] [Full Text] [Related]

  • 37. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP.
    Adv Biochem Psychopharmacol; 1987 Dec 04; 43():183-200. PubMed ID: 3035886
    [Abstract] [Full Text] [Related]

  • 38. HPA axis activation determined by the CRH challenge test in patients with few versus multiple episodes of treatment-refractory depression.
    Ehnvall A, Sjögren M, Zachrisson OC, Agren H.
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec 04; 254(6):349-55. PubMed ID: 15538608
    [Abstract] [Full Text] [Related]

  • 39. Hypothalamic-pituitary-adrenal (HPA) axis response to exogenous corticotropin-releasing hormone (CRH) is attenuated in men with chronic insomnia.
    Vgontzas AN, Fernandez-Mendoza J, Lenker KP, Basta M, Bixler EO, Chrousos GP.
    J Sleep Res; 2022 Jun 04; 31(3):e13526. PubMed ID: 34825417
    [Abstract] [Full Text] [Related]

  • 40. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS, Cetinkalp S, Tunay S, Polat I, Simsek F, Aksoy B, Kizilates G, Erdogan Y, Coburn KL.
    J Psychiatr Res; 2017 Feb 04; 85():66-74. PubMed ID: 27837659
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.